During the early months of the COVID-19 pandemic, Pepticom identified the opportunity to apply its artificial intelligence (AI) platform to rapidly generate high-quality peptide molecules that ...

After this presentation you will discover how Cyclic CPPs may finally realize the potential originally hoped for cell-penetrating peptides.

In November 2021, researchers at Northwestern University introduced an innovative therapy using fast-moving "dancing ...

Like the broad concept of cyclic recessions and ... presents considerable challenges in drug development due to its known association with addiction (Waldhoer et. al. 2004). KORs, primarily activated ...

The U.S. Food and Drug Administration late Thursday approved ... xanomeline for Alzheimer’s disease and found that it had potent antipsychotic properties. Despite xanomeline’s promise, the ...

Tissue engineering and regenerative studies are areas of scientific investigation that aim to repair or replace damaged tissues and organs. Scientists speculate that peptide blends might play a key ...

One of the features that distinguishes it from its constituent ingredients, however, is the bi-weekly eight-to-12-hour service that begins with all congregants, young and old, consuming the potent ...

to efficiently produce a potent inhibitor of a cancer-promoting integrin. "The ability to generate lasso peptide diversity is important for optimizing drugs," said Mark Burk, CEO of Lassogen.

The first patient has been dosed in a trial assessing the peptide-drug conjugate CBX-12 in patients with platinum-resistant or refractory ovarian cancer, according to a press release from Cybrexa ...

The demand for highly sought-after weight-loss drugs continues to rise ... Anti-obesity medications "exert potent effects throughout the body, particularly the gastrointestinal tract," according ...

Drug-induced lupus is more common in men because they are given these drugs more often; however, not everyone who takes these drugs will develop the disease. Specific criteria for diagnosing ...

Upon binding to a ligand – which can range from small molecules like cyclic ... potent agonist nanobody pN162. The pN162-MC4R-Gs-Nb35 structure shows its distinct binding mode compared to ...